Bio / Pharma trial + FDA approval calendar.
November PDUFA calendar, updated 📅
Already read out:
$NRXP / ANDA approved early on Oct 30 (GDUFA date was Nov 10) / our Positive call hit / stock closed -14.7%
$AGIO / PDUFA pushed to Feb 1, 2027
Still ahead (13 FDA decisions):
Nov 14
$SMMT / Ivonescimab + chemo / EGFRm NSCLC
$CYTK / Aficamten / oHCM (label expansion)
solana:JJnFfDLQ5cSm5m36vBdTpS7zoPyoC4w7RAbkqj2pump / BXCL501 / Agitation in schizophrenia & bipolar
Nov 22
$CAPR / Deramiocel / DMD
$SVRA / Molgramostim / aPAP
Nov 27
$BBIO / BBP-418 / LGMD
$GSK / Neladalkib / ALK+ NSCLC
Nov 28
$PYPD / D-PLEX-100 / SSI
Nov 30
$COGT / Bezuclastinib + sunitinib / GIST
$RHHBY / Giredestrant / ER+/HER2- breast cancer
$VRTX / Povetacicept / IgAN
Date TBA
$REGN / Cemdisiran / Myasthenia gravis
$RHHBY / Gazyva / Primary membranous nephropathy
The image shows the first 6 decisions still ahead. $SMMT, $CAPR & $SVRA odds are unlocked.
$CYTK and solana:JJnFfDLQ5cSm5m36vBdTpS7zoPyoC4w7RAbkqj2pump odds are coming soon.
Seems like following Nancy Pelosi inside trading might make sense following democrats winning House and Senate midterms.
Remember that in Covid she was the voice of democrats leading House.
IMO results good for Biotech/Pharma, less for Data Centers (both need eachother anyway).
That's literally best analyse for anyone in doubt what time on the market we're in TECHNICALLY now.
As we know anything can happen in these unstable times but personally I'm bullish for Biotech heading towards 2027.
Would consider picking top quantum plays while still cheap.
Hedge funds just hit the panic button harder than at any time in the last ten years. Here is why that is good news for you.
Morgan Stanley tracks the total money its hedge fund clients have bet on stocks. When that total drops sharply, it means funds are being forced to cut positions, usually because their losses hit a limit. In the last 2 days, it fell 7.8%, a bigger unwind than the Covid crash, the GameStop squeeze, or the 2016 and 2018 selloffs.
Every time this number fell past 6% (2016, 2018 twice, 2020, 2021, 2025), the S&P 500 bottomed within a week or two and was higher one, three and six months later. Six out of six.
The reason is simple. Once the forced sellers have sold, there is nobody left to push prices down. Those same funds then have to buy back in, and that buying has powered every rebound in the table.
As for me, I am looking for great businesses that got dumped for no reason. That is where the bargains are.
One $PACB DNA read tell scientists what the DNA sequence is, how it is packaged inside the cell, which regions are accessible to proteins, and which parts are chemically methylated.
Multiple layers of DNA information from a single molecule, rather then separate experiments.
New on hg38: Fiber-seq, from the Stergachis and Vollger labs. One PacBio read reports sequence, chromatin accessibility and CpG methylation together, and is long enough to phase.
See our news for more: bit.ly/ucscGBfiberseq

ALT The imprinting control region of the KCNQ1OT1 long non-coding RNA on chromosome 11, in K562. Across the highlighted region the CpGs on one haplotype are nearly all methylated and those on the other are nearly all unmethylated, and it is the unmethylated haplotype that is open. The bottom track plots the difference between the two, red where it is most significant. Loss of methylation here has been associated with Beckwith-Wiedemann syndrome.
Binance exploit might be a solid boost for $XMR going towards ath imo.
Imo $OCUL is worth adding to the list, if things go well as it seems like it should trade at least $20+, key approval confirmation pending.
$PACB has it's motion towards Earnings soon, wondering if it's gonna show similar scenario to last years tops/bottoms. Key thing is to break $4 otherwise we might still see pullbacks to the bottom areas.
So many partnerships came last months, question is if its priced in yet.
$PACB ✅️
Unbelievable that $700 stock sitting at $163 per share.
Not if but when✅️ $AVAV
🚨 US Army releases footage of high-energy laser weapon operating at US southern border
Soldier assigned to Joint Task Force-Southern Border operate an Army Multi-Purpose High Energy Laser (AMP-HEL) mounted on a Joint Light Tactical Vehicle in preparation to respond to increased drone activity near Rio Grande City, Texas on Aug. 31, 2026 dvidshub.net/video/1022178/j…
$AVAV does that✅️
중국이 연구중인 드론을 무력화하는 방법
Readers added context they thought people might want to know
이 영상은 중국이 연구 중인 실제 드론 중화 기술이 아닌 AI 생성 가짜 콘텐츠입니다.
factcheck.afp.com/doc.afp.com.C6…
$AVAV deal after deal, chart bottomed and earnings tomorrow.
Intresting setup not gonna lie.
First international LOCUST order. Over $50M.
Drone threats are growing in scale and complexity. Directed energy gives defenders a smarter way to keep pace.
avinc.com/2026/09/08/av-secu…
















